Anonymous
Guest
Anonymous
Guest
Tests are being ordered everyday and lives are being changed.
The question though is how many tests are being ordered everyday. Is the business growing enough to slow the burn rate significantly?
We can all understand your frustration, money being wasted, inside politics, neurotic employees...
Apparently there is a consensus with the other poster's list of negatives about this company.
There's a need for this test, although it's not clearly defined; we will be defining it in the near future.
If this notion were disclosed to a potential investor (that the need is not clearly defined) I believe said investor would walk away from the deal. If this is a current employee who is writing this, this illustrates a major problem, as it is a clear indication that the company really doesn't currently know what the clinical utility of their test is.
Most urologists love the concept of more accurate information.
Who doesn't? The question as the last poster puts it is, what do you do with the information?
Once we can show them how it can impact their treatment decisions this company will be going places.
Again, very risky - this is called the "create our own market" paradigm. This rarely succeeds.